{"filing":{"accession_number":"0001193125-26-425271","cik":"0000917520","ticker":"IART","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","form":"8-K","filing_date":"2026-10-19","report_date":"2026-10-19","primary_document":"d142199d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/917520/000119312526425271/d142199d8k.htm"},"events":[{"id":36097,"run_id":33282,"accession_number":"0001193125-26-425271","anchor_item_number":"2.03","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"On October 19, 2026, Integra completed a refinancing transaction consisting of (1) a private offering of $450 million in 9.500% Senior Secured Notes due 2033, and (2) an amended and restated credit agreement providing $1.65 billion in aggregate commitments. The company used proceeds to refinance existing debt obligations.","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","ticker":"IART","filing_date":"2026-10-19","form":"8-K","submitted_at":null,"items":[{"id":40381,"accession_number":"0001193125-26-425271","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into two material debt obligations on October 19, 2026: (1) an amended and restated credit agreement providing $1.65 billion in aggregate commitments across revolving and term loan facilities, and (2) completion of a private offering of $450 million in 9.500% Senior Secured Notes due 2033. Both constitute creation of direct financial obligations and are clearly material to investors assessing the company's capital structure and financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"","ticker":null,"filing_date":""},{"id":40382,"accession_number":"0001193125-26-425271","item_number":"1.02","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses termination of the Existing Credit Agreement and refinancing through a new $1.65 billion credit facility and $450 million senior secured notes offering. While Item 1.02 addresses termination of a material agreement, the substance of the disclosure centers on the creation of new direct financial obligations (the Notes and amended Credit Facility) rather than merely the termination itself. The press release confirms the company \"closed a private offering of $450.0 million aggregate principal amount of 9.500% senior secured notes due 2033\" and amended its credit facility, making debt_issuance the more salient classification than a pure termination event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"","ticker":null,"filing_date":""},{"id":40383,"accession_number":"0001193125-26-425271","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Integra closed a private offering of $450 million in 9.500% senior secured notes due 2033 and amended its credit facility to approximately $1.65 billion total, creating direct financial obligations. The Item 2.03 disclosure and the press release confirm completion of these refinancing transactions, which constitute material debt issuances and credit facility amendments.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"","ticker":null,"filing_date":""},{"id":40384,"accession_number":"0001193125-26-425271","item_number":"7.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the closing of a $450 million private offering of 9.500% senior secured notes due 2033 and the amendment and restatement of an existing credit facility totaling approximately $1.65 billion. These transactions represent the creation of new direct financial obligations and refinancing of existing debt, which is the core definition of debt_issuance. The materiality is evident from the substantial principal amounts involved and the company's use of proceeds to refinance existing obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40381,"accession_number":"0001193125-26-425271","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses entry into two material debt obligations on October 19, 2026: (1) an amended and restated credit agreement providing $1.65 billion in aggregate commitments across revolving and term loan facilities, and (2) completion of a private offering of $450 million in 9.500% Senior Secured Notes due 2033. Both constitute creation of direct financial obligations and are clearly material to investors assessing the company's capital structure and financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","ticker":"IART","filing_date":"2026-10-19"},{"id":40382,"accession_number":"0001193125-26-425271","item_number":"1.02","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses termination of the Existing Credit Agreement and refinancing through a new $1.65 billion credit facility and $450 million senior secured notes offering. While Item 1.02 addresses termination of a material agreement, the substance of the disclosure centers on the creation of new direct financial obligations (the Notes and amended Credit Facility) rather than merely the termination itself. The press release confirms the company \"closed a private offering of $450.0 million aggregate principal amount of 9.500% senior secured notes due 2033\" and amended its credit facility, making debt_issuance the more salient classification than a pure termination event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","ticker":"IART","filing_date":"2026-10-19"},{"id":40383,"accession_number":"0001193125-26-425271","item_number":"2.03","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Integra closed a private offering of $450 million in 9.500% senior secured notes due 2033 and amended its credit facility to approximately $1.65 billion total, creating direct financial obligations. The Item 2.03 disclosure and the press release confirm completion of these refinancing transactions, which constitute material debt issuances and credit facility amendments.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","ticker":"IART","filing_date":"2026-10-19"},{"id":40384,"accession_number":"0001193125-26-425271","item_number":"7.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses the closing of a $450 million private offering of 9.500% senior secured notes due 2033 and the amendment and restatement of an existing credit facility totaling approximately $1.65 billion. These transactions represent the creation of new direct financial obligations and refinancing of existing debt, which is the core definition of debt_issuance. The materiality is evident from the substantial principal amounts involved and the company's use of proceeds to refinance existing obligations.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-19T20:21:57.600674+00:00","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","ticker":"IART","filing_date":"2026-10-19"}]}